ACOG Practice Bulletin No. 228: Management of Symptomatic Uterine Leiomyomas: Correction
In “ACOG Practice Bulletin No. 228: Management of Symptomatic Uterine Leiomyomas” from the American College of Obstetricians and Gynecologists,1 there is an error in the last statement on page e101. The term “type 5 leiomyomas” should read, “type 2–5 leiomyomas.” The full, corrected statement is as follows: “Magnetic resonance imaging can be useful in surgical planning, determining vascularity and degeneration, and distinguishing between type 4 and type 2–5 leiomyomas, in which there is an intramural component, with or without a submucosal component (Fig. 1) (4).”
© 2021 by the American College of Obstetricians and Gynecologists. Published by Wolters Kluwer Health, Inc. All rights reserved.
1. Management of symptomatic uterine leiomyomas. ACOG Practice Bulletin No. 228. American College of Obstetricians and Gynecologists. Obstet Gynecol 2021;137:e100–15. doi: 10.1097/AOG.0000000000004401